Autolus

London, United Kingdom

Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.

$350.0M raised

Feb 2024

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Autolus raised?

Autolus has raised $350.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2024.

Who are Autolus's investors?

Autolus's investors include Cormorant Asset Management, Blackstone Group, Google Ventures, 4BIO Capital, Nextech Invest.

Where is Autolus headquartered?

Autolus is headquartered in London, United Kingdom.

What does Autolus do?

Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.

What stage is Autolus at?

Autolus is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 8, 2024.

MLA

"Autolus — Funding & Investors." VCBacked, February 8, 2024, https://www.vcbacked.co/company/autolus. Accessed July 1, 2026.

APA

VCBacked. (2024). Autolus — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/autolus

Wikipedia (cite web)

{{cite web |title=Autolus — Funding & Investors |url=https://www.vcbacked.co/company/autolus |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 8, 2024.